Thursday, 22nd September h. 11.30 – 12.45 (CET)
Parallel session
Hot issues in the pharmaceutical sector: between regulation and competition
Managed by Fréget Glaser & Associés
After focusing over the last 10-15 years mainly on pay-for-delay cases, EU and national antitrust authorities are increasingly shifting their scrutiny to a broader range of practices, including disparagement, ‘legally unfounded interventions’, excessive pricing. While some of these continue to deal with fair access to market by generics, others raise questions about handling information submitted to health regulators or other public authorities, what is a ‘fair price’ and who should determine it.
Chair
- Liliana Eskenazi, Partner, Fréget Glaser & Associés
Speakers
- Olivier Fréget, Partner, Fréget Glaser & Associés
- Fleur Herrenschmidt, Head Legal Region Europe, Novartis Pharma AG
- Grímur Jóhannsson, Legal Manager, European Federation of Pharmaceutical Industries and Associations (EFPIA)